These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36776074)

  • 1. Mortality Risks and Causes of Death by Dementia Types in a Japanese Cohort with Dementia: NCGG-STORIES.
    Ono R; Sakurai T; Sugimoto T; Uchida K; Nakagawa T; Noguchi T; Komatsu A; Arai H; Saito T
    J Alzheimers Dis; 2023; 92(2):487-498. PubMed ID: 36776074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of pneumonia complications on the prognosis of patients with autopsy-confirmed Alzheimer's disease, dementia with Lewy bodies, and vascular dementia.
    Manabe T; Mizukami K; Akatsu H; Teramoto S; Yamaoka K; Nakamura S; Ohkubo T; Kudo K; Hizawa N
    Psychogeriatrics; 2016 Sep; 16(5):305-14. PubMed ID: 26510708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
    Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
    J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal volumes predict risk of dementia with Lewy bodies in mild cognitive impairment.
    Kantarci K; Lesnick T; Ferman TJ; Przybelski SA; Boeve BF; Smith GE; Kremers WK; Knopman DS; Jack CR; Petersen RC
    Neurology; 2016 Nov; 87(22):2317-2323. PubMed ID: 27807186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic Resonance Imaging in Stable Mild Cognitive Impairment, Prodromal Alzheimer's Disease, and Prodromal Dementia with Lewy Bodies.
    Siddiqui TG; Whitfield T; Praharaju SJ; Sadiq D; Kazmi H; Ben-Joseph A; Walker Z
    Dement Geriatr Cogn Disord; 2020; 49(6):583-588. PubMed ID: 33227783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prodromal Dementia With Lewy Bodies: Clinical Characterization and Predictors of Progression.
    van de Beek M; van Steenoven I; van der Zande JJ; Barkhof F; Teunissen CE; van der Flier WM; Lemstra AW
    Mov Disord; 2020 May; 35(5):859-867. PubMed ID: 32048343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic diversity among patients with cognitive complaints: A 3-year follow-up study in a memory clinic.
    Kao SL; Chen SC; Li YY; Lo RY
    Int J Geriatr Psychiatry; 2019 Dec; 34(12):1900-1906. PubMed ID: 31486134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of mild cognitive impairment tending to convert into Alzheimer's disease or dementia with Lewy bodies: A follow-up study in a memory clinic.
    Kondo D; Ota K; Kasanuki K; Fujishiro H; Chiba Y; Murayama N; Sato K; Hirayasu Y; Arai H; Iseki E
    J Neurol Sci; 2016 Oct; 369():102-108. PubMed ID: 27653873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of Death According to Death Certificates in Individuals with Dementia: A Cohort from the Swedish Dementia Registry.
    Garcia-Ptacek S; Kåreholt I; Cermakova P; Rizzuto D; Religa D; Eriksdotter M
    J Am Geriatr Soc; 2016 Nov; 64(11):e137-e142. PubMed ID: 27801938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality in dementia with Lewy bodies compared with Alzheimer's dementia: a retrospective naturalistic cohort study.
    Price A; Farooq R; Yuan JM; Menon VB; Cardinal RN; O'Brien JT
    BMJ Open; 2017 Nov; 7(11):e017504. PubMed ID: 29101136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRS in mild cognitive impairment: early differentiation of dementia with Lewy bodies and Alzheimer's disease.
    Zhang B; Ferman TJ; Boeve BF; Smith GE; Maroney-Smith M; Spychalla AJ; Knopman DS; Jack CR; Petersen RC; Kantarci K
    J Neuroimaging; 2015; 25(2):269-274. PubMed ID: 25039916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease.
    Williams MM; Xiong C; Morris JC; Galvin JE
    Neurology; 2006 Dec; 67(11):1935-41. PubMed ID: 17159097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodromal Dementia with Lewy Bodies and Prodromal Alzheimer's Disease: A Comparison of the Cognitive and Clinical Profiles.
    Sadiq D; Whitfield T; Lee L; Stevens T; Costafreda S; Walker Z
    J Alzheimers Dis; 2017; 58(2):463-470. PubMed ID: 28453473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early differentiation of dementia with Lewy bodies and Alzheimer's disease: Heart rate variability at mild cognitive impairment stage.
    Kim MS; Yoon JH; Hong JM
    Clin Neurophysiol; 2018 Aug; 129(8):1570-1578. PubMed ID: 29883835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
    Shea YF; Ha J; Chu LW
    Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-onset dementia is associated with higher mortality.
    Koedam EL; Pijnenburg YA; Deeg DJ; Baak MM; van der Vlies AE; Scheltens P; van der Flier WM
    Dement Geriatr Cogn Disord; 2008; 26(2):147-52. PubMed ID: 18679029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood mRNA Expression in Alzheimer's Disease and Dementia With Lewy Bodies.
    Donaghy PC; Cockell SJ; Martin-Ruiz C; Coxhead J; Kane J; Erskine D; Koss D; Taylor JP; Morris CM; O'Brien JT; Thomas AJ
    Am J Geriatr Psychiatry; 2022 Sep; 30(9):964-975. PubMed ID: 35283023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and psychological symptoms of dementia and mortality risk among people with cognitive impairment: an 8-year longitudinal study from the NCGG-STORIES.
    Noguchi T; Nakagawa T; Sugimoto T; Komatsu A; Kuroda Y; Uchida K; Ono R; Arai H; Sakurai T; Saito T
    J Epidemiol; 2024 Mar; ():. PubMed ID: 38522914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid α-synuclein and Lewy body-like symptoms in normal controls, mild cognitive impairment, and Alzheimer's disease.
    Mackin RS; Insel P; Zhang J; Mohlenhoff B; Galasko D; Weiner M; Mattsson N
    J Alzheimers Dis; 2015; 43(3):1007-16. PubMed ID: 25125463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.